Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated With Percutaneous Coronary Intervention

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 3150 participants.

Also called NCT06692140

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 3,150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06692140
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06692140. Randomized; single masking; primary purpose treatment. Start 2024-11-16 (actual); primary completion 2028-07-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated With Percutaneous Coronary Intervention
Acronym
SORT OUT XII
Condition
Ischemia, Myocardial
Intervention (Device)
Ultra-low strut thickness everolimus-eluting biodegradable polymer Evermine50 stent(s)
Intervention (Device)
PCI with Everolimus-eluting stents (durable polymer everolimus-eluting Xience or Promus stent(s))
Lead sponsor
Odense University Hospital (class: other)

Record details

Record id
cardio:ct-nct06692140
Content hash
e2a0ab733a17b6eaa3339b1b523bbd51a5cbeaccb2dc125428869290541decdc